Amendment #488 to H3400

Extended Release and Long-Acting opioid medications

Mr. Collins of Boston moves to amend the bill by adding the following section:

"SECTION XXXX. Notwithstanding any rule, regulation, special or general law to the contrary, the department of public health shall issue, no later than October 31, 2015, mitigation guidelines on the prescription of the class of potent pain medicines known as extended-release and long-acting (ER/LA) opioid analgesics to include co-prescription of an opioid antagonist, approved by the U.S. Food and Drug Administration (FDA), and labeled for administration by family members or caregivers in a non-medically supervised environment."